In a randomized placebo-controlled clinical study in women with high breast cancer risk, the effects of RES on the expression of some cancer-related genes, such as CCND-2, p16, RASSF-1α, and cancer-promoting prostaglandin E2 (PGE2), were assessed [518]. Here, RASSF1 is linked to cancer.